Andrew Spokes portfolio, Q4 2025
Farallon Capital Management · 13F for the quarter ending Dec 31, 2025
For Q4 2025, Farallon Capital Management reported $20.3B across 150 US-listed positions, led by RVMD (5.7%), MSFT (5.3%) and AMZN (5.1%). Compared with its filing for Q3 2025, Andrew Spokes opened 32 new positions, added to 22, reduced 34 and sold out of 21; 62 positions did not change.
The largest purchase was a new position in Electronic Arts Inc ($1B); the largest sale, the sale of the whole position in ADSK ($528.2M).
Key facts
- 13F portfolio value
- $20.3BQ4 2025
- Positions
- 150
- Largest holding
- RVMD 5.7%
- New positions
- 32
- Sold out
- 21
- Filed
- Feb 17, 2026
Holdings as of (Q4 2025), filed with the SEC on and amended on . Changes are measured against the filing for Sep 30, 2025. Every tracked investor's Q4 2025 13F.
The cover page of this filing states a total of $20.7B; its table adds up to $21.2B. The figures here are the table's.
Bought and sold in Q4 2025
| Stock | Move | Shares | Size | Of portfolio |
|---|---|---|---|---|
Electronic Arts Incno ticker on file | ▲ New | +5.04M | $1B | 5.07% |
| Kenvue IncKVUE | ▲ New | +41.48M | $715.4M | 3.53% |
Exact Sciences Corpno ticker on file | ▲ New | +6.41M | $650.5M | 3.21% |
| Autodesk IncADSK | ▼ Sold out | −1.66M | $528.2M | 2.60% |
CyberArk Software Ltdno ticker on file | ▲ New | +1.05M | $469.7M | 2.32% |
| Synopsys IncSNPS | ▲ New | +999.2K | $469.3M | 2.31% |
| Thermo Fisher Scientific IncTMO | ▼ Reduced 49% | −622.56K | $360.7M | 1.78% |
| TransUnionTRU | ▼ Reduced 86% | −4.06M | $347.9M | 1.71% |
Warner Bros Discovery Incno ticker on file | ▲ New | +11.57M | $333.5M | 1.64% |
| IntuitINTU | ▼ Sold out | −488.09K | $333.3M | 1.64% |
Kellanovano ticker on file | ▼ Sold out | −3.94M | $323.5M | 1.59% |
| Analog Devices IncADI | ▼ Sold out | −1.3M | $319.3M | 1.57% |
| Salesforce IncCRM | ▼ Reduced 49% | −1.2M | $318.2M | 1.57% |
| Broadcom IncAVGO | ▲ New | +892.4K | $308.9M | 1.52% |
| KKR & Co. IncKKR | ▲ New | +2.02M | $257.2M | 1.27% |
| Boston Scientific CorpBSX | ▲ Added 57% | +2.69M | $256.8M | 1.27% |
| iShares Bitcoin Trust ETFIBIT | ▼ Reduced 69% | −4.86M | $241.1M | 1.19% |
| Hims & Hers Health IncHIMS | ▼ Reduced 68% | −7.36M | $239M | 1.18% |
Avidity Biosciences Incno ticker on file | ▲ New | +3.23M | $233.2M | 1.15% |
| Amazon.com IncAMZN | ▲ Added 28% | +994.19K | $229.5M | 1.13% |
Dayforce Incno ticker on file | ▲ New | +2.93M | $202.3M | 1.00% |
| Bitwise 10 Crypto Index ETFBITW | ▲ New | +3.39M | $198.9M | 0.98% |
| Norfolk Southern CorpNSC | ▼ Sold out | −615K | $184.8M | 0.91% |
| IQVIA Holdings IncIQV | ▼ Sold out | −938.55K | $178.3M | 0.88% |
| Exelixis IncEXEL | ▼ Reduced 19% | −3.79M | $166.2M | 0.82% |
| Woodward IncWWD | ▼ Sold out | −621.97K | $157.2M | 0.77% |
| Teva Pharmaceutical IndustriesTEVA | ▼ Reduced 99% | −4.96M | $154.7M | 0.76% |
| Microsoft CorpMSFT | ▲ Added 16% | +300.94K | $145.5M | 0.72% |
| Aon PLCAON | ▲ Added 17% | +387.22K | $136.6M | 0.67% |
| iShares Ethereum Trust ETFETHA | ▼ Reduced 80% | −5.97M | $133.9M | 0.66% |
| Lantheus Holdings IncLNTH | ▲ Added 56% | +1.95M | $129.8M | 0.64% |
| The Walt Disney CoDIS | ▼ Reduced 21% | −1.07M | $122.1M | 0.60% |
| New York Times Co MTN BeNYT | ▼ Reduced 34% | −1.71M | $118.4M | 0.58% |
| Alphabet IncGOOG | ▼ Reduced 30% | −333.9K | $104.8M | 0.52% |
| CBRE Group IncCBRE | ▼ Reduced 39% | −632.27K | $101.7M | 0.50% |
| UnitedHealth Group IncUNH | ▼ Reduced 15% | −287.59K | $94.9M | 0.47% |
| Grail IncGRAL | ▲ Added 74% | +993.68K | $85M | 0.42% |
| Natera IncNTRA | ▼ Reduced 8.0% | −339.09K | $77.7M | 0.38% |
| Mara Holdings IncMARA | ▼ Sold out | −3.66M | $66.8M | 0.33% |
| Cardinal Health IncCAH | ▲ Added 128% | +323K | $66.4M | 0.33% |
| Welltower IncWELL | ▲ New | +343K | $63.7M | 0.31% |
| Bridgebio Pharma IncBBIO | ▲ Added 9.8% | +806.46K | $61.7M | 0.30% |
| Nasdaq IncNDAQ | ▼ Reduced 17% | −633.83K | $61.6M | 0.30% |
| WabtecWAB | ▲ Added 12% | +270.91K | $57.8M | 0.29% |
| Abivax SAABVX | ▼ Reduced 52% | −418K | $56.4M | 0.28% |
Crinetics Pharmaceuticalsno ticker on file | ▲ Added 20% | +1.16M | $54.1M | 0.27% |
| Oscar Health IncOSCR | ▼ Reduced 93% | −3.38M | $48.5M | 0.24% |
| Grayscale Coindesk CryptoGDLC | ▼ Sold out | −851.19K | $47.6M | 0.23% |
MR Cooper Group Incno ticker on file | ▼ Sold out | −222K | $46.8M | 0.23% |
| Nektar TherapeuticsNKTR | ▼ Sold out | −791K | $45M | 0.22% |
| Encompass Health CorpEHC | ▼ Reduced 59% | −336.5K | $35.7M | 0.18% |
| Flutter Entertainment PLCFLUT | ▼ Sold out | −137.37K | $34.9M | 0.17% |
| Visa IncV | ▲ Added 16% | +96.1K | $33.7M | 0.17% |
| Structure Therapeutics IncGPCR | ▲ New | +454K | $31.6M | 0.16% |
| Mineralys Therapeutics IncMLYS | ▼ Reduced 51% | −849.76K | $30.8M | 0.15% |
Sunococorp LLCno ticker on file | ▲ New | +606.28K | $29.9M | 0.15% |
Perceptive Cap Solutionsno ticker on file | ▲ New | +2.25M | $29.3M | 0.14% |
| Waystar Holding CorpWAY | ▼ Sold out | −750K | $28.4M | 0.14% |
Cidara Therapeutics Incno ticker on file | ▼ Reduced 25% | −125.2K | $27.7M | 0.14% |
Centessa Pharmaceuticals PLCno ticker on file | ▲ Added 24% | +1.05M | $26.2M | 0.13% |
Terns Pharmaceuticals Incno ticker on file | ▲ New | +642K | $25.9M | 0.13% |
| Tyra Biosciences IncTYRA | ▲ Added 81% | +923K | $24.3M | 0.12% |
| Mastercard IncMA | ▼ Reduced 19% | −41.1K | $23.5M | 0.12% |
| Mckesson CorpMCK | ▼ Reduced 8.6% | −28.2K | $23.1M | 0.11% |
| Tango Therapeutics IncTNGX | ▲ Added 21% | +2.3M | $20.4M | 0.10% |
| New Oriental ED & TechnologyEDU | ▼ Reduced 65% | −369.15K | $20.3M | 0.10% |
| Surgery Partners IncSGRY | ▼ Sold out | −871.83K | $18.9M | 0.09% |
| Amkor Technology IncAMKR | ▲ New | +464K | $18.3M | 0.09% |
| Agios Pharmaceuticals IncAGIO | ▼ Reduced 11% | −621.56K | $16.9M | 0.08% |
| Verastem IncVSTM | ▲ New | +2M | $15.4M | 0.08% |
| Baidu IncBIDU | ▲ Added 52% | +107.3K | $14M | 0.07% |
| AramarkARMK | ▲ Added 4.0% | +360.84K | $13.3M | 0.07% |
| Uniqure NVQURE | ▼ Reduced 98% | −551K | $13.2M | 0.06% |
| Prime Medicine IncPRME | ▼ Reduced 74% | −3.51M | $12.2M | 0.06% |
| Medline IncMDLN | ▲ New | +260K | $10.9M | 0.05% |
| Intellia Therapeutics IncNTLA | ▼ Sold out | −607.2K | $10.5M | 0.05% |
| Guardant Health IncGH | ▲ Added more than 10× | +101K | $10.3M | 0.05% |
| Enanta Pharmaceuticals IncENTA | ▲ Added 31% | +650K | $10.3M | 0.05% |
| Tectonic Therapeutic IncTECX | ▼ Sold out | −640K | $10M | 0.05% |
| Minerva Neurosciences IncNERV | ▲ New | +2.37M | $9.5M | 0.05% |
| Savara IncSVRA | ▼ Sold out | −2.5M | $8.9M | 0.04% |
| The Charles Schwab CorpSCHW | ▲ Added 2.7% | +88K | $8.8M | 0.04% |
| GeneDx Holdings CorpWGS | ▲ Added more than 10× | +65K | $8.5M | 0.04% |
| Tenet Healthcare CorpTHC | ▼ Reduced 10% | −41.85K | $8.3M | 0.04% |
Soleno Therapeutics Incno ticker on file | ▼ Reduced 97% | −148K | $6.9M | 0.03% |
| Vnet Group IncVNET | ▲ Added 15% | +796.27K | $6.7M | 0.03% |
| Grayscale Ethereum Mini TrustETH | ▲ New | +228.34K | $6.4M | 0.03% |
iShares Trustno ticker on file | ▼ Sold out | −18.91K | $5.1M | 0.03% |
Allete Incno ticker on file | ▼ Sold out | −75K | $5M | 0.02% |
| Protagonist Therapeutics IncPTGX | ▼ Reduced 0.8% | −52K | $4.5M | 0.02% |
| Novavax IncNVAX | ▼ Reduced 75% | −585K | $3.9M | 0.02% |
| Schrodinger IncSDGR | ▼ Reduced 75% | −213K | $3.8M | 0.02% |
| Revolution Medicines IncRVMD | ▼ Reduced 0.3% | −42.9K | $3.4M | 0.02% |
| Liquidia CorporationLQDA | ▲ Added 1.1% | +90.4K | $3.1M | 0.02% |
| JOYY IncJOYY | ▼ Reduced 7.5% | −46.8K | $3M | 0.01% |
| Doximity IncDOCS | ▼ Reduced 17% | −63K | $2.8M | 0.01% |
| Celcuity IncCELC | ▲ New | +4K | $399K | 0.00% |
| Omeros CorpOMER | ▲ New | +23K | $395K | 0.00% |
| Stoke Therapeutics IncSTOK | ▲ New | +9K | $285.7K | 0.00% |
Merus N Vno ticker on file | ▼ Sold out | −3K | $282.5K | 0.00% |
| Nuvation Bio IncNUVB | ▲ New | +29K | $259.8K | 0.00% |
| Vaxcyte IncPCVX | ▲ New | +5K | $230.7K | 0.00% |
| Neogenomics IncNEO | ▲ New | +19K | $223.4K | 0.00% |
| Establishment Labs Holdings IncESTA | ▲ New | +3K | $218.6K | 0.00% |
| Ocular Therapeutix IncOCUL | ▲ New | +18K | $218.5K | 0.00% |
| Ultragenyx PharmaceuticalRARE | ▼ Sold out | −7K | $210.6K | 0.00% |
| Precigen IncPGEN | ▲ New | +50K | $209K | 0.00% |
| Adaptive Biotechnologies CorpADPT | ▲ New | +11K | $178.6K | 0.00% |
| Rani Therapeutics Holdings-ARANI | ▲ New | +78K | $105.3K | 0.00% |
Holdings at the quarter's end
| # | Stock | Sector | Share of portfolio | Value | Shares | Reported price | Held | Since Q3 2025 |
|---|---|---|---|---|---|---|---|---|
| 1 | Revolution Medicines IncRVMD | Health Care | 5.73% | $1.2B | 14.58M | $79.65 | 6+ qtrs | ▼ Reduced 0.3% |
| 2 | Microsoft CorpMSFT | Technology | 5.28% | $1.1B | 2.21M | $483.62 | 6+ qtrs | ▲ Added 16% |
| 3 | Amazon.com IncAMZN | Consumer Discretionary | 5.12% | $1B | 4.5M | $230.82 | 3 qtrs | ▲ Added 28% |
| 4 | Electronic Arts Incno ticker on file | — | 5.07% | $1B | 5.04M | $204.33 | 1 qtr | New |
| 5 | Aon PLCAON · SHS CL A | Financials | 4.64% | $940.5M | 2.67M | $352.88 | 6+ qtrs | ▲ Added 17% |
| 6 | Natera IncNTRA | Health Care | 4.42% | $896.7M | 3.91M | $229.09 | 6+ qtrs | ▼ Reduced 8.0% |
| 7 | Kenvue IncKVUE | — | 3.53% | $715.4M | 41.48M | $17.25 | 1 qtr | New |
| 8 | Boston Scientific CorpBSX | Health Care | 3.50% | $709.4M | 7.44M | $95.35 | 6+ qtrs | ▲ Added 57% |
| 9 | Exelixis IncEXEL | Health Care | 3.39% | $688.5M | 15.71M | $43.83 | 6+ qtrs | ▼ Reduced 19% |
| 10 | Bridgebio Pharma IncBBIO | Health Care | 3.39% | $688.3M | 9M | $76.49 | 6+ qtrs | ▲ Added 9.8% |
| 11 | Exact Sciences Corpno ticker on file | — | 3.21% | $650.5M | 6.41M | $101.56 | 1 qtr | New |
| 12 | Protagonist Therapeutics IncPTGX | Health Care | 2.65% | $536.6M | 6.14M | $87.34 | 6+ qtrs | ▼ Reduced 0.8% |
| 13 | WabtecWAB | Industrials | 2.61% | $528.5M | 2.48M | $213.45 | 6+ qtrs | ▲ Added 12% |
| 14 | UnitedHealth Group IncUNH | Health Care | 2.60% | $527.8M | 1.6M | $330.11 | 6+ qtrs | ▼ Reduced 15% |
| 15 | CyberArk Software Ltdno ticker on file · SHS | — | 2.32% | $469.7M | 1.05M | $446.06 | 1 qtr | New |
| 16 | The Walt Disney CoDIS | Communication | 2.31% | $469.4M | 4.13M | $113.77 | 6+ qtrs | ▼ Reduced 21% |
| 17 | Synopsys IncSNPS | Technology | 2.31% | $469.3M | 999.2K | $469.72 | 1 qtr | New |
| 18 | Thermo Fisher Scientific IncTMO | Health Care | 1.82% | $368.3M | 635.69K | $579.45 | 6+ qtrs | ▼ Reduced 49% |
| 19 | Lantheus Holdings IncLNTH | Health Care | 1.78% | $361.2M | 5.43M | $66.55 | 6+ qtrs | ▲ Added 56% |
| 20 | AramarkARMK | Consumer Discretionary | 1.70% | $344.9M | 9.36M | $36.86 | 6+ qtrs | ▲ Added 4.0% |
| 21 | Salesforce IncCRM | Technology | 1.65% | $334.1M | 1.26M | $264.91 | 6+ qtrs | ▼ Reduced 49% |
| 22 | The Charles Schwab CorpSCHW | Financials | 1.65% | $333.7M | 3.34M | $99.91 | 5 qtrs | ▲ Added 2.7% |
| 23 | Warner Bros Discovery Incno ticker on file | — | 1.64% | $333.5M | 11.57M | $28.82 | 1 qtr | New |
| 24 | Crinetics Pharmaceuticalsno ticker on file | — | 1.59% | $322.7M | 6.93M | $46.55 | 6+ qtrs | ▲ Added 20% |
| 25 | Broadcom IncAVGO | Technology | 1.52% | $308.9M | 892.4K | $346.10 | 1 qtr | New |
| 26 | Liquidia CorporationLQDA | — | 1.47% | $298.5M | 8.66M | $34.49 | 6+ qtrs | ▲ Added 1.1% |
| 27 | Nasdaq IncNDAQ | Financials | 1.43% | $290.3M | 2.99M | $97.13 | 6+ qtrs | ▼ Reduced 17% |
| 28 | Beam Therapeutics IncBEAM | — | 1.38% | $278.9M | 10.06M | $27.72 | 6+ qtrs | No change |
| 29 | KKR & Co. IncKKR | Financials | 1.27% | $257.2M | 2.02M | $127.48 | 1 qtr | New |
| 30 | Alphabet IncGOOG · CAP STK CL C | — | 1.22% | $247M | 787.04K | $313.80 | 6+ qtrs | ▼ Reduced 30% |
| 31 | Mckesson CorpMCK | Health Care | 1.21% | $245.2M | 298.9K | $820.29 | 5 qtrs | ▼ Reduced 8.6% |
| 32 | Visa IncV | Financials | 1.20% | $244.1M | 695.91K | $350.71 | 6+ qtrs | ▲ Added 16% |
| 33 | Avidity Biosciences Incno ticker on file | — | 1.15% | $233.2M | 3.23M | $72.13 | 1 qtr | New |
| 34 | New York Times Co MTN BeNYT · CL A | Communication | 1.12% | $227.7M | 3.28M | $69.42 | 6+ qtrs | ▼ Reduced 34% |
| 35 | Dayforce Incno ticker on file | — | 1.00% | $202.3M | 2.93M | $69.16 | 1 qtr | New |
| 36 | Grail IncGRAL | Health Care | 0.99% | $200.5M | 2.34M | $85.59 | 3 qtrs | ▲ Added 74% |
| 37 | Bitwise 10 Crypto Index ETFBITW · UNIT BENEFICIAL | — | 0.98% | $198.9M | 3.39M | $58.76 | 1 qtr | New |
| 38 | CBRE Group IncCBRE · CL A | Real Estate | 0.78% | $158.2M | 983.77K | $160.79 | 6+ qtrs | ▼ Reduced 39% |
| 39 | Agios Pharmaceuticals IncAGIO | — | 0.69% | $140.4M | 5.16M | $27.22 | 6+ qtrs | ▼ Reduced 11% |
| 40 | Centessa Pharmaceuticals PLCno ticker on file · SPONSORED ADS | — | 0.66% | $134.5M | 5.38M | $25.01 | 6+ qtrs | ▲ Added 24% |
| 41 | Beta Bionics IncBBNX | — | 0.65% | $131.4M | 4.31M | $30.47 | 4 qtrs | No change |
| 42 | Cardinal Health IncCAH | Health Care | 0.58% | $118.4M | 576K | $205.50 | 4 qtrs | ▲ Added 128% |
| 43 | Tango Therapeutics IncTNGX | — | 0.57% | $115.7M | 13.06M | $8.86 | 5 qtrs | ▲ Added 21% |
| 44 | Hims & Hers Health IncHIMS | Health Care | 0.54% | $110M | 3.39M | $32.47 | 6+ qtrs | ▼ Reduced 68% |
| 45 | iShares Bitcoin Trust ETFIBIT · SHS BEN INT | — | 0.52% | $106.1M | 2.14M | $49.65 | 6+ qtrs | ▼ Reduced 69% |
| 46 | Mastercard IncMA · CL A | Financials | 0.49% | $98.6M | 172.67K | $570.88 | 6+ qtrs | ▼ Reduced 19% |
| 47 | Cidara Therapeutics Incno ticker on file | — | 0.42% | $84.6M | 382.8K | $220.89 | 3 qtrs | ▼ Reduced 25% |
| 48 | Tenet Healthcare CorpTHC | Health Care | 0.37% | $74M | 372.15K | $198.72 | 3 qtrs | ▼ Reduced 10% |
| 49 | Welltower IncWELL | Real Estate | 0.31% | $63.7M | 343K | $185.61 | 1 qtr | New |
| 50 | TransUnionTRU | Industrials | 0.29% | $57.9M | 675K | $85.75 | 6+ qtrs | ▼ Reduced 86% |
| 51 | Tyra Biosciences IncTYRA | — | 0.27% | $54.3M | 2.07M | $26.29 | 5 qtrs | ▲ Added 81% |
| 52 | Vnet Group IncVNET · SPONSORED ADS A | — | 0.26% | $53.2M | 6.29M | $8.46 | 6+ qtrs | ▲ Added 15% |
| 53 | Abivax SAABVX · SPONSORED ADS | Health Care | 0.26% | $52.2M | 387K | $134.86 | 2 qtrs | ▼ Reduced 52% |
| 54 | Enanta Pharmaceuticals IncENTA | — | 0.22% | $43.7M | 2.77M | $15.77 | 6+ qtrs | ▲ Added 31% |
| 55 | Assembly Biosciences IncASMB | — | 0.21% | $41.8M | 1.23M | $34.01 | 2 qtrs | No change |
| 56 | Baidu IncBIDU · SPON ADR REP A | Technology | 0.20% | $41.2M | 315.3K | $130.66 | 2 qtrs | ▲ Added 52% |
| 57 | JOYY IncJOYY · ADS REPSTG COM A | — | 0.19% | $37.4M | 578.2K | $64.76 | 4 qtrs | ▼ Reduced 7.5% |
| 58 | iShares Ethereum Trust ETFETHA · SHS | — | 0.16% | $33.2M | 1.48M | $22.43 | 2 qtrs | ▼ Reduced 80% |
| 59 | Structure Therapeutics IncGPCR · SPONSORED ADS | — | 0.16% | $31.6M | 454K | $69.55 | 1 qtr | New |
| 60 | Mineralys Therapeutics IncMLYS | — | 0.15% | $29.9M | 823.3K | $36.29 | 2 qtrs | ▼ Reduced 51% |
| 61 | Sunococorp LLCno ticker on file | — | 0.15% | $29.9M | 606.28K | $49.28 | 1 qtr | New |
| 62 | Perceptive Cap Solutionsno ticker on file · CL A ORD SHS | — | 0.15% | $29.3M | 2.25M | $13.03 | 1 qtr | New |
| 63 | Terns Pharmaceuticals Incno ticker on file | — | 0.13% | $25.9M | 642K | $40.40 | 1 qtr | New |
| 64 | Encompass Health CorpEHC | Health Care | 0.12% | $24.9M | 234.5K | $106.14 | 6+ qtrs | ▼ Reduced 59% |
| 65 | Amkor Technology IncAMKR | Technology | 0.09% | $18.3M | 464K | $39.48 | 1 qtr | New |
| 66 | Verastem IncVSTM | — | 0.08% | $15.4M | 2M | $7.72 | 1 qtr | New |
| 67 | Doximity IncDOCS · CL A | Technology | 0.07% | $13.8M | 311K | $44.28 | 2 qtrs | ▼ Reduced 17% |
| 68 | Guardant Health IncGH | Health Care | 0.06% | $11.1M | 109K | $102.14 | 3 qtrs | ▲ Added more than 10× |
| 69 | Medline IncMDLN | Health Care | 0.05% | $10.9M | 260K | $42.00 | 1 qtr | New |
| 70 | New Oriental ED & TechnologyEDU · SPON ADR | Consumer Discretionary | 0.05% | $10.8M | 196K | $55.03 | 6+ qtrs | ▼ Reduced 65% |
| 71 | Minerva Neurosciences IncNERV | — | 0.05% | $9.5M | 2.37M | $4.02 | 1 qtr | New |
| 72 | GeneDx Holdings CorpWGS | — | 0.05% | $9.1M | 70K | $130.06 | 5 qtrs | ▲ Added more than 10× |
| 73 | Grayscale Ethereum Mini TrustETH · SHS NEW | — | 0.03% | $6.4M | 228.34K | $28.06 | 1 qtr | New |
| 74 | Prime Medicine IncPRME | — | 0.02% | $4.3M | 1.24M | $3.47 | 6+ qtrs | ▼ Reduced 74% |
| 75 | Oscar Health IncOSCR · CL A | Health Care | 0.02% | $3.8M | 264K | $14.37 | 6+ qtrs | ▼ Reduced 93% |
| 76 | Madrigal Pharmaceuticals IncMDGL | Health Care | 0.01% | $1.9M | 3.32K | $582.34 | 6+ qtrs | No change |
| 77 | Summit Midstream CorporationSMC | — | 0.01% | $1.6M | 58.21K | $26.68 | 6+ qtrs | No change |
| 78 | Novavax IncNVAX | — | 0.01% | $1.3M | 195K | $6.72 | 6+ qtrs | ▼ Reduced 75% |
| 79 | Schrodinger IncSDGR | — | 0.01% | $1.3M | 71K | $17.88 | 3 qtrs | ▼ Reduced 75% |
| 80 | Teva Pharmaceutical IndustriesTEVA · SPONSORED ADS | Health Care | 0.01% | $1.2M | 40K | $31.21 | 2 qtrs | ▼ Reduced 99% |
| 81 | Capricor Therapeutics IncCAPR | — | 0.01% | $1.2M | 41K | $28.86 | 5 qtrs | No change |
| 82 | Arrowhead PharmaceuticalsARWR | Health Care | 0.01% | $1M | 15.8K | $66.39 | 5 qtrs | No change |
| 83 | Alvotech SAALVO · ORDINARY SHARES | — | 0.01% | $1M | 199.68K | $5.13 | 6+ qtrs | No change |
| 84 | Brightspring Health Services IncBTSG | Health Care | 0.00% | $823.9K | 22K | $37.45 | 6+ qtrs | No change |
| 85 | Roivant Sciences LtdROIV · SHS | Health Care | 0.00% | $802.9K | 37K | $21.70 | 6+ qtrs | No change |
| 86 | Arcutis Biotherapeutics IncARQT | — | 0.00% | $755K | 26K | $29.04 | 6+ qtrs | No change |
| 87 | Axsome Therapeutics IncAXSM | Health Care | 0.00% | $730.6K | 4K | $182.64 | 6+ qtrs | No change |
| 88 | Cogent Biosciences IncCOGT | Health Care | 0.00% | $603.8K | 17K | $35.52 | 6+ qtrs | No change |
| 89 | Alkermes PLCALKS · SHS | Health Care | 0.00% | $582K | 20.8K | $27.98 | 4 qtrs | No change |
| 90 | Insmed IncINSM | Health Care | 0.00% | $522.1K | 3K | $174.04 | 6+ qtrs | No change |
| 91 | Krystal Biotech IncKRYS | Health Care | 0.00% | $493.1K | 2K | $246.54 | 6+ qtrs | No change |
| 92 | Progyny IncPGNY | — | 0.00% | $462.2K | 18K | $25.68 | 6+ qtrs | No change |
| 93 | Travere Therapeutics IncTVTX | Health Care | 0.00% | $458.5K | 12K | $38.21 | 3 qtrs | No change |
| 94 | Healthequity IncHQY | Health Care | 0.00% | $458.1K | 5K | $91.61 | 6+ qtrs | No change |
| 95 | Celcuity IncCELC | — | 0.00% | $399K | 4K | $99.74 | 1 qtr | New |
| 96 | Omeros CorpOMER | — | 0.00% | $395K | 23K | $17.18 | 1 qtr | New |
| 97 | Ionis Pharmaceuticals IncIONS | Health Care | 0.00% | $379.7K | 4.8K | $79.11 | 2 qtrs | No change |
| 98 | Livanova PLCLIVN · SHS | Health Care | 0.00% | $369.2K | 6K | $61.53 | 4 qtrs | No change |
| 99 | Globus Med IncGMED · CL A | Health Care | 0.00% | $349.2K | 4K | $87.31 | 6+ qtrs | No change |
| 100 | Cencora IncCOR | Health Care | 0.00% | $337.8K | 1K | $337.75 | 6+ qtrs | No change |
| 101 | Uniqure NVQURE · SHS | — | 0.00% | $335K | 14K | $23.93 | 4 qtrs | ▼ Reduced 98% |
| 102 | Beone Medicines LtdONC · SPONSORED ADS | Health Care | 0.00% | $334.2K | 1.1K | $303.81 | 6+ qtrs | No change |
| 103 | CG Oncology IncCGON | Health Care | 0.00% | $332.2K | 8K | $41.52 | 3 qtrs | No change |
| 104 | Scholar Rock Holding CorpSRRK | Health Care | 0.00% | $308.4K | 7K | $44.05 | 5 qtrs | No change |
| 105 | Immunovant IncIMVT | Health Care | 0.00% | $305K | 12K | $25.42 | 6+ qtrs | No change |
| 106 | Nuvalent Incno ticker on file | — | 0.00% | $301.8K | 3K | $100.59 | 6+ qtrs | No change |
| 107 | Ascendis Pharma A/SASND · SPONSORED ADR | Health Care | 0.00% | $298.5K | 1.4K | $213.24 | 4 qtrs | No change |
| 108 | Veracyte IncVCYT | — | 0.00% | $294.7K | 7K | $42.10 | 2 qtrs | No change |
| 109 | Glaukos CorpGKOS | Health Care | 0.00% | $293.6K | 2.6K | $112.91 | 6+ qtrs | No change |
| 110 | Solid Power Incno ticker on file · *W EXP 12/08/202 | — | 0.00% | $286.9K | 405.32K | $0.7078 | 6+ qtrs | No change |
| 111 | Stoke Therapeutics IncSTOK | — | 0.00% | $285.7K | 9K | $31.74 | 1 qtr | New |
| 112 | Sabra Health Care REIT IncSBRA | Real Estate | 0.00% | $265.2K | 14K | $18.94 | 6+ qtrs | No change |
| 113 | Merit Med Systems IncMMSI | Health Care | 0.00% | $264.4K | 3K | $88.14 | 6+ qtrs | No change |
| 114 | Grifols S AGRFS · SP ADR REP B NVT | Health Care | 0.00% | $261.8K | 28K | $9.35 | 6+ qtrs | No change |
| 115 | Arcellx Incno ticker on file | — | 0.00% | $260.8K | 4K | $65.20 | 6+ qtrs | No change |
| 116 | Nuvation Bio IncNUVB | — | 0.00% | $259.8K | 29K | $8.96 | 1 qtr | New |
| 117 | UroGen Pharma LtdURGN | — | 0.00% | $257.6K | 11K | $23.42 | 2 qtrs | No change |
| 118 | Pacific Biosciences of California IncPACB | — | 0.00% | $252.5K | 135K | $1.87 | 6+ qtrs | No change |
| 119 | GE HealthCare Technologies IncGEHC | Health Care | 0.00% | $246.1K | 3K | $82.02 | 5 qtrs | No change |
| 120 | Twist Bioscience CorpTWST | Health Care | 0.00% | $242.7K | 7.65K | $31.72 | 6+ qtrs | No change |
| 121 | Mirum Pharmaceuticals IncMIRM | Health Care | 0.00% | $237K | 3K | $78.99 | 2 qtrs | No change |
| 122 | Soleno Therapeutics Incno ticker on file | — | 0.00% | $231.5K | 5K | $46.30 | 5 qtrs | ▼ Reduced 97% |
| 123 | Vaxcyte IncPCVX | Health Care | 0.00% | $230.7K | 5K | $46.14 | 1 qtr | New |
| 124 | Amicus Therapeuticno ticker on file | — | 0.00% | $227.8K | 16K | $14.24 | 6+ qtrs | No change |
| 125 | Aleanna Incno ticker on file | — | 0.00% | $223.4K | 78.4K | $2.85 | 5 qtrs | No change |
| 126 | Neogenomics IncNEO | — | 0.00% | $223.4K | 19K | $11.76 | 1 qtr | New |
| 127 | Icon Pub Ltd CoICLR · SHS | Health Care | 0.00% | $218.7K | 1.2K | $182.22 | 2 qtrs | No change |
| 128 | Establishment Labs Holdings IncESTA | — | 0.00% | $218.6K | 3K | $72.88 | 1 qtr | New |
| 129 | Ocular Therapeutix IncOCUL | — | 0.00% | $218.5K | 18K | $12.14 | 1 qtr | New |
| 130 | Syndax Pharmaceuticals IncSNDX | — | 0.00% | $210.1K | 10K | $21.01 | 6+ qtrs | No change |
| 131 | Precigen IncPGEN | — | 0.00% | $209K | 50K | $4.18 | 1 qtr | New |
| 132 | Healthcare Realty TrustHR · CL A COM | Real Estate | 0.00% | $203.4K | 12K | $16.95 | 6+ qtrs | No change |
| 133 | Dyne Therapeutics IncDYN | — | 0.00% | $195.6K | 10K | $19.56 | 6+ qtrs | No change |
| 134 | BioCryst Pharmaceuticals IncBCRX | — | 0.00% | $187.2K | 24K | $7.80 | 2 qtrs | No change |
| 135 | Tvardi Therapeutics IncTVRD | — | 0.00% | $185.9K | 43.23K | $4.30 | 3 qtrs | No change |
| 136 | Adaptive Biotechnologies CorpADPT | Health Care | 0.00% | $178.6K | 11K | $16.24 | 1 qtr | New |
| 137 | Aleanna Incno ticker on file · *W EXP 12/13/202 | — | 0.00% | $163.5K | 990K | $0.1652 | 5 qtrs | No change |
| 138 | Ardelyx IncARDX | — | 0.00% | $134.1K | 23K | $5.83 | 6+ qtrs | No change |
| 139 | Blue Gold Ltdno ticker on file · *W EXP 04/01/203 | — | 0.00% | $132K | 300K | $0.4400 | 2 qtrs | No change |
| 140 | Revolution Medicines Incno ticker on file · *W EXP 12/17/202 | — | 0.00% | $112.9K | 120.09K | $0.9399 | 6+ qtrs | No change |
| 141 | Rani Therapeutics Holdings-ARANI | — | 0.00% | $105.3K | 78K | $1.35 | 1 qtr | New |
| 142 | Altimmune IncALT | — | 0.00% | $99.6K | 27.6K | $3.61 | 6+ qtrs | No change |
| 143 | Iovance Biotherapeutics IncIOVA | — | 0.00% | $71K | 26K | $2.73 | 6+ qtrs | No change |
| 144 | Geron CorpGERN | — | 0.00% | $56.8K | 43K | $1.32 | 6+ qtrs | No change |
| 145 | Evolent Health IncEVH · CL A | — | 0.00% | $56K | 14K | $4.00 | 6+ qtrs | No change |
| 146 | C4 Therapeutics IncCCCC | — | 0.00% | $53.5K | 28K | $1.91 | 6+ qtrs | No change |
| 147 | Ironwood Pharmaceuticals IncIRWD | — | 0.00% | $43.8K | 13K | $3.37 | 6+ qtrs | No change |
| 148 | Canopy Growth CorporationCGC | — | 0.00% | $34.2K | 30K | $1.14 | 6+ qtrs | No change |
| 149 | Nvni Group Limitedno ticker on file · *W EXP 11/01/202 | — | 0.00% | $22.5K | 375K | $0.0600 | 6+ qtrs | No change |
| 150 | Beyond Meat IncBYND | — | 0.00% | $15.6K | 19K | $0.8200 | 6+ qtrs | No change |
By sector
| Sector | Share of portfolio | Value | Positions |
|---|---|---|---|
| Health Care | 33.5% | $6.8B | 49 |
| Technology | 11.1% | $2.3B | 7 |
| Financials | 10.7% | $2.2B | 6 |
| Consumer Discretionary | 6.87% | $1.4B | 3 |
| Communication | 3.44% | $697.2M | 2 |
| Industrials | 2.89% | $586.4M | 2 |
| Real Estate | 1.10% | $222.3M | 4 |
| No sector on file | 30.4% | $6.2B | 77 |
Questions and answers
What did Andrew Spokes own in Q4 2025?
Farallon Capital Management's 13F for Q4 2025 lists 150 positions worth $20.3B. The largest: RVMD (5.7%), MSFT (5.3%), AMZN (5.1%), Electronic Arts Inc (5.1%), AON (4.6%).
What did Andrew Spokes buy in Q4 2025?
The largest purchases, by the shares bought at the quarter-end price the filing implies: Electronic Arts Inc (new, $1B), KVUE (new, $715.4M), Exact Sciences Corp (new, $650.5M), CyberArk Software Ltd (new, $469.7M), SNPS (new, $469.3M), Warner Bros Discovery Inc (new, $333.5M).
What did Andrew Spokes sell in Q4 2025?
The largest sales: ADSK (sold out, $528.2M), TMO (reduced, $360.7M), TRU (reduced, $347.9M), INTU (sold out, $333.3M), Kellanova (sold out, $323.5M), ADI (sold out, $319.3M).
When was this filing made?
Farallon Capital Management filed its 13F for the quarter ending Dec 31, 2025 on Feb 17, 2026, and amended it on Nov 16, 2026; the figures here include the amendment. A 13F is due within 45 days of the quarter's end, so the positions were already weeks old when it became public.
Learn
Cite this page
Funkfolio, “Andrew Spokes portfolio, Q4 2025: Farallon Capital Management 13F holdings”, data as of 16 November 2026. https://funkfolio.com/gurus/farallon/2025-q4
Underlying data: SEC EDGAR, Form 13F-HR of Farallon Capital Management (CIK 909661) for the period ending Dec 31, 2025.
Source: SEC EDGAR, Form 13F-HR for Farallon Capital Management (CIK 909661), period ending Dec 31, 2025, filed Feb 17, 2026, amended Nov 16, 2026. Changes compare share counts with the filing for Sep 30, 2025; a share split in between is allowed for where one is on record. “Reported price” is a position's reported value divided by its shares. The size of a buy or sell is the change in shares at that price; a position sold out is sized at its value in the previous filing, and “of portfolio” sets the size against the $20.3B reported for this quarter. “Held” counts consecutive quarterly filings up to this one, out of the 6 looked at from here back. Sectors are those of the ranked companies on this site as they stand today. 6 option positions in the filing are not shown. Not a live portfolio and not advice.